LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Home・Akcijų sąrašas・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Uždarymo kaina

9.19 0.55

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.92

Max

9.32

Pagrindiniai rodikliai
By Trading Economics
Pajamos	4.2M -23M
Pelno marža	-2,027.003
Darbuotojai	83
EBITDA	6.6M -23M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+49.35% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	80M 666M
Ankstesnė atidarymo kaina	8.64
Ankstesnė uždarymo kaina	9.19

Ventyx Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-24 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

2025-12-26 20:22; UTC

Rinkos pokalbiai

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

2025-12-26 20:13; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

2025-12-26 19:24; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

2025-12-26 17:45; UTC

Rinkos pokalbiai

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

2025-12-26 15:52; UTC

Rinkos pokalbiai

Oil Futures Turn Lower After Steady Start -- Market Talk

2025-12-26 14:58; UTC

Rinkos pokalbiai

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

2025-12-26 14:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

2025-12-26 14:28; UTC

Rinkos pokalbiai

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

2025-12-26 13:47; UTC

Rinkos pokalbiai

Oil Futures Steady in Thin Holiday Trade -- Market Talk

2025-12-26 07:22; UTC

Rinkos pokalbiai

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

2025-12-26 05:03; UTC

Rinkos pokalbiai

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

2025-12-26 03:38; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-26 03:38; UTC

Rinkos pokalbiai

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

2025-12-26 02:44; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-26 02:44; UTC

Rinkos pokalbiai

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

2025-12-26 01:39; UTC

Rinkos pokalbiai

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

2025-12-26 01:14; UTC

Rinkos pokalbiai

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

2025-12-26 00:34; UTC

Rinkos pokalbiai

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

2025-12-26 00:15; UTC

Rinkos pokalbiai

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

2025-12-25 23:42; UTC

Rinkos pokalbiai

Nikkei May Trade in Range; Yen in Focus -- Market Talk

2025-12-25 23:40; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

2025-12-25 00:20; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

2025-12-24 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

2025-12-24 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

2025-12-24 19:35; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-24 19:35; UTC

Rinkos pokalbiai

Treasury Yields Decline Ahead of Christmas -- Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

2025-12-24 19:06; UTC

Rinkos pokalbiai

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

Akcijų palyginimas

Kainos pokytis

Ventyx Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

49.35% į viršų

12 mėnesių prognozė

Vidutinis 13.71 USD 49.35%

Aukščiausias 21 USD

Žemiausias 2 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ventyx Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Ventyx Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.